Please fill in your details to download the Table of Contents of this report for free. We also do customization of these reports so you can write to us at email@example.com in case you need any other additional information.
HeiQ Viroblock is among the first textile technologies in the world to be proven effective in laboratory testing against SARS-CoV-2, the virus from the coronavirus family that causes COVID-19. It has been shown to be 99.99 per cent effective in 30 minutes in tests conducted with the Peter Doherty Institute for Infection and Immunity in Melbourne, Australia.
The Coats Innovation Hub – America in North Carolina, US, is adapting HeiQ Viroblock technology to create a new range of threads and engineered yarns suitable for application across a wide range of end-use products. Non-toxic and hypoallergenic, HeiQ Viroblock merges microsilver technology to attract virus particles which then combine with vesicle technology to break down the viral membrane within seconds. The microsilver technology uses recycled silver to enhance its sustainable offering, while the vesicle technology is bio-based.
"The combination of HeiQ Viroblock technology with our specialist expertise in threads and yarns creates a unique and powerful textile solution for the challenges we see today. The innovation infrastructure we have built at Coats continues to deliver exciting industry changing concepts that have real large-scale commercial potential," Ronan Cox, president, Performance Materials, Coats, said.
Coats prides itself on its innovation which has become a key focus following the development of its three Innovation Hubs in China, Turkey and the US. These centres provide the opportunity for technical experts from Coats to work alongside industry partners and customers in real time on dedicated machinery to develop ground-breaking solutions for all the industries Coats supplies.
"We are certainly very delighted that Coats, the world’s leading threads and yarns producer, is adapting HeiQ Viroblock. This technology can be applied to any fabric to add an antiviral efficacy to them. Now with Coats threads and yarns, it is even possible for every stitch holding the fabric together to deliver the same effect, leaving no chance for harmful microorganisms," Carlo Centonze, co-founder and CEO, HeiQ Group, said.
Earlier in April this year, Coats joined the Gerber Task Force as a coalition partner. Created by Gerber Technology, the Task Force empowers manufacturers to switch to personal protective equipment (PPE) production and match supply and demand for critically needed products.
Fibre2Fashion News Desk (RKS)
| On 28th Sep 2020
The potential loss of tariff advantages offered by the European Union ...
| On 28th Sep 2020
Following a 66 per cent spike in daily online sales in May, when most ...
| On 28th Sep 2020
An independent review launched by Boohoo in July has “has identified...
Surat dominates foiling, embossing and pleating
Competition is the best thing that can happen to a startup
‘There has been an increase in demand for water based inks, rather than...
Shanghai-based Aura Designs Ltd is a leading manufacturer of textile and...
The Sleep Company was established to upgrade the sleep quality of every...
Ronald Van Den Broek
Headquartered in Japan, Mimaki Engineering Co. Ltd. manufactures and...
About one in every 20 patients picks up an infection while hospitalised....
UK-based Pireta has developed a unique free-form process to add durable,...
Focusing on bold patterns and colour palettes, Luis Quijano, a student at...
Golfwear and menswear brand Devereux is set for greener pastures. Robert...
Tahweave & Garo
Designer Sweta Tantia owns Garo, a couture indutva or ethnicwear brand,...
Somaiya Kala Vidya
Among the many honours showered on Frater, including Fulbright and Ford...
Letter to Editor
Subscribe today and get the latest update on Textiles, Fashion, Apparel and so on.
Subscribe today and get the latest information on Textiles, Fashion, Apparel.